Viridian Therapeutics
VRDN
VRDN
51 hedge funds and large institutions have $37.4M invested in Viridian Therapeutics in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
-5
Holders Change %
-8.93%
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
3
Increased
19
Reduced
13
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
FAM
Formidable Asset Management
Cincinnati,
Ohio
|
+$430K |
| 2 |
Millennium Management
New York
|
+$196K |
| 3 |
6CM
683 Capital Management
New York
|
+$193K |
| 4 |
MFAM
Motley Fool Asset Management
Alexandria,
Virginia
|
+$80.2K |
| 5 |
D.E. Shaw & Co
New York
|
+$74.1K |
Top Sellers
| 1 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$2.76M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.17M |
| 3 |
SG Americas Securities
New York
|
-$301K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$252K |
| 5 |
Morgan Stanley
New York
|
-$189K |
